EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Atherogenic Activities of Exopolysaccharides and Their Producing Strain Limosilactobacillus fermentum MC1 in Mice

Nada Oršolić iD, Barbara Toljanić, Dyana Odeh iD, Nina Čuljak iD, Kate Šešelja iD, Mirela Baus Lončar iD, Domagoj Đikić, Andreja Leboš Pavunc, Blaženka Kos iD

International Journal of Molecular Sciences · 07.03.2026 · 27 (5) · 2473

DOI: 10.3390/ijms27052473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.03.2026. Verfasst von Nada Oršolić und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Animal Physiology, Faculty of Science, University of Zagreb, Horvatovac 102a, 10 000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Atherosclerosis, Limosilactobacillus fermentum, Polysaccharides, Bacterial, Probiotics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Croatian Science Foundation, University of Zagreb Faculty of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis, the leading cause of death worldwide, is a chronic inflammatory disease leading to the accumulation of lipid-rich plaques within the artery wall. Accumulating evidence indicates that intestinal microbiota plays an important regulatory role in atherosclerosis at all stages of the disease. Through numerous metabolites, the intestinal microbiota can regulate immune and inflammatory cells and their mediators, as well as lipid metabolism, thereby contributing to the development and progression of atherosclerosis. With these assumptions in mind, we investigated the possibility of using Limosilactobacillus fermentum MC1 (L. fermentum MC1) and its exopolysaccharides (EPSs) in the reduction of lipid and atherogenic parameters as a preventive strategy in preventing the occurrence of cardiovascular diseases (CVD). We investigated the effect of L. fermentum MC1 and its EPSs on the health status of mice by monitoring the following parameters: body weight, colon length and weight, relative weight of organs, hematological (Hgb, WBC, number of erythrocytes, MCHC, MCV, MCH), and biochemical blood parameters including glucose, serum enzymes (ALT, ALP, amylase), urea, creatinine and lipid profile (total cholesterol, triglycerides, HDL, VLDL, LDL), different atherogenic parameters, blood biomarkers such as lymphocyte-to-monocyte (LMR) and neutrophil-to-lymphocyte (NLR) ratios, molecular inflammatory markers (IL1β, IL6, MCP1, IL1α, TLR4, TNFα, CD68, TGFβ), apoptosis markers (BCL2, AIFM1, IGF-1R), and endoplasmic reticulum stress markers (CHOP and GRP94) as well as oxidative stress (NOX2) markers in the colon. Furthermore, the level of lipid peroxidation, nitric oxide and glutathione concentrations in the liver, kidneys and spleen were measured. L. fermentum MC1 and its EPSs may prevent the development of atherosclerosis and the progression of CVD through antioxidant, anti-inflammatory, immunomodulatory activities, and regulation of the gut microbiome and lipid metabolism. The observed reduction in lipid and atherogenic determinants suggests that L. fermentum MC1 and its EPSs may contribute to atheroprotection and confer multiple health benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisLimosilactobacillus fermentumPolysaccharides, BacterialProbioticsAnimalsFemaleMiceCytokinesImmunomodulationMice, Inbred C57BLLipidsColon

Stichwörter der Autor:innen

L. fermentum MC1atherogenic parametersexopolysaccharideslipid profilemolecular inflammatory markersoxidative stress

Substanzen

CytokinesPolysaccharides, BacterialLipids

Autor:innen und Institutionen

  • Division of Animal Physiology, Faculty of Science, University of Zagreb, Horvatovac 102a, 10 000 Zagreb, Croatia.
  • Department of Biochemical Engineering, Faculty of Food Technology and Biotechnology, University of Zagreb, Pierottijeva 6, 10 000 Zagreb, Croatia.
  • Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10 000 Zagreb, Croatia.

ORCID-Profile: Nada Oršolić, Dyana Odeh, Nina Čuljak, Kate Šešelja, Mirela Baus Lončar, Blaženka Kos

Förderung

  • The Croatian Science Foundation
  • University of Zagreb Faculty of Science

Zitieren

APA

Oršolić, N., Toljanić, B., Odeh, D., Čuljak, N., Šešelja, K., Baus Lončar, M., Đikić, D., Leboš Pavunc, A., & Kos, B. (2026). Anti-Atherogenic Activities of Exopolysaccharides and Their Producing Strain Limosilactobacillus fermentum MC1 in Mice. International Journal of Molecular Sciences, 27(5), 2473. https://doi.org/10.3390/ijms27052473

Vancouver

Oršolić N, Toljanić B, Odeh D, Čuljak N, Šešelja K, Baus Lončar M, et al. Anti-Atherogenic Activities of Exopolysaccharides and Their Producing Strain Limosilactobacillus fermentum MC1 in Mice. International Journal of Molecular Sciences. 2026;27(5):2473. doi:10.3390/ijms27052473

BibTeX
@article{Oroli2026,
  author = {Oršolić, Nada and Toljanić, Barbara and Odeh, Dyana and Čuljak, Nina and Šešelja, Kate and Baus Lončar, Mirela and Đikić, Domagoj and Leboš Pavunc, Andreja and Kos, Blaženka},
  title = {Anti-Atherogenic Activities of Exopolysaccharides and Their Producing Strain Limosilactobacillus fermentum MC1 in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2473},
  doi = {10.3390/ijms27052473}
}
Kostenlos starten →